JNHMF Stock — Jack Nathan Medical Corp

Jack Nathan Medical Corp (JNHMF)

Updated October 15, 2026.

JNHMF is a Stock. Total return is -99.9% over the past 6 years, 244.6 points behind SPY at 144.7%.

Jack Nathan Medical Corp. designs, builds, and operates medical clinics across Canada and Mexico, offering aesthetic and wellness services including injectables, skin rejuvenation, and laser treatments through its Jack Nathan MedSpa platform, along with primary care, virtual care, and allied health services such as physiotherapy and chiropractic care. The company does not currently have an established distribution schedule. This stock may appeal to investors seeking exposure to the healthcare and medical aesthetics sectors.

JNHMF performance versus SPY

Price and return data through 2026-10-15.

Total return is -99.9% over the past 6 years, 244.6 points behind SPY at 144.7%. Over the past year its total return — price change plus distributions reinvested — is 0.0%. Its deepest 1-year drawdown was 94.1%.

JNHMF key facts

Asset type

Stock

Asset class

Equity

Inception date

10/19/2020

Distribution frequency

None

Last close

$0.0010 (as of 2026-10-15)

Market cap

$87,099

Average volume

0.0

Beta

-0.312

Payout ratio

0.0%

EPS

$0.00

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

JNHMF risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 94.1%.

Who may consider JNHMF — and who may not

It is a weaker fit for investors who need monthly cash flow (JNHMF does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on JNHMF

• All tickers starting with J

Tagged: Healthcare.

Frequently asked questions